# Organic Hemp Food Products · 99-39 · DENMARK — FDA import alert red lists: firms subject to detention without physical examination

For Organic Hemp Food Products · 99-39 · DENMARK, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is DENMARK; product is Hemp Oil | Hemp Oil | Hemp Oil | Hemp Oil; product code is 28 O - - 99 Essential Oils for Flavoring, n.e.c. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 H - - 99 Fats and Lipid Substances, N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C; date published is 06/22/2015; address is Center Boulevard 5 , Copenhagen S, DENMARK, verified against its source on 2026-09-16.

- **Firm:** Organic Hemp Food Products _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** DENMARK _(verified: appears in the quote below)_
- **Address:** Center Boulevard 5 , Copenhagen S, DENMARK _(verified: appears in the quote below)_
- **Date published:** 06/22/2015 _(verified: appears in the quote below)_
- **Product code:** 28 O - - 99 Essential Oils for Flavoring, n.e.c. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 H - - 99 Fats and Lipid Substances, N.E.C. | 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. _(verified: each item appears in the quote below)_
- **Product:** Hemp Oil | Hemp Oil | Hemp Oil | Hemp Oil _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 | The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 _(verified: each item appears in the quote below)_

## What the source says

> Organic Hemp Food Products Date Published : 06/22/2015 Center Boulevard 5 , Copenhagen S, DENMARK 28 O - - 99 Essential Oils for Flavoring, n.e.c. Date Published: 06/22/2015 Desc: Hemp Oil Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 06/22/2015 Desc: Hemp Oil Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 54 H - - 99 Fats and Lipid Substances, N.E.C. Date Published: 06/22/2015 Desc: Hemp Oil Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015 66 Y - - 99 Exhibits - Other Drug Related Items N.E.C. Date Published: 06/22/2015 Desc: Hemp Oil Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(y) of the Act [21 U.S.C.343(y)] in that the label fails to bear a domestic address or domestic phone number through which the responsible person (as described in section 761) may receive a report of a serious adverse event with such dietary supplement. The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the product is misbranded within the meaning of 403(q)(5)(F) of the Act [21 U.S.C. § 343(q)(5)(F)]because the presentation of the nutrition information on the product labeling does not comply with 21 CFR 101.36. Published on 06/23/2015

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).